HOME › DRUGS › ATOGEPANT
ACTIVE SUBSTANCE / INN

ATOGEPANT

Brand name(s): QULIPTA, Aquipta
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Migraine Disorders
NDA215206
ACTIVE SUBSTANCE
Atogepant
REGULATORS
FDA · EMA
SPONSORS / MAH
AbbVie Deutschland GmbH & Co. KG, ABBVIE
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
QULIPTANDA215206ABBVIEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AquiptaAbbVie Deutschland GmbH & Co. KGAuthorised11/08/2023Migraine Disorders

FULL INTELLIGENCE ON ATOGEPANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →